A role for peroxisome proliferator-activated receptor α (PPARα) in the control of cardiac malonyl-CoA levels -: Reduced fatty acid oxidation rates and increased glucose oxidation rates in the hearts of mice lacking PPARα are associated with higher concentrations of maloncyl-CoA and reduced expression of malonyl-CoA decarboxlase

被引:208
作者
Campbell, FM
Kozak, R
Wagner, A
Altarejos, JY
Dyck, JRB
Belke, DD
Severson, DL
Kelly, DP
Lopaschuk, GD
机构
[1] Univ Alberta, Dept Pharmacol, Edmonton, AB T6G 2S2, Canada
[2] Univ Alberta, Dept Pediat, Edmonton, AB T6G 2S2, Canada
[3] Univ Calgary, Dept Pharmacol & Therapeut, Calgary, AB T2N 4N1, Canada
[4] Washington Univ, Sch Med, Div Cardiovasc, Cardiovasc Res Ctr, St Louis, MO 63110 USA
关键词
D O I
10.1074/jbc.M106054200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Peroxisome proliferator-activated receptor alpha (PPAR)alpha is a nuclear receptor transcription factor that has an important role in controlling cardiac metabolic gene expression. We determined whether mice lacking PPARalpha (PPARalpha (-/-) mice) have alterations in cardiac energy metabolism. Rates of palmitate oxidation were significantly decreased in isolated working hearts from PPARalpha (-/-) hearts compared with hearts from age-matched wild type mice (PPARalpha (+/+) mice), (62 +/- 12 versus 154 +/- 65 nmol/g dry weight/min, respectively, p < 0.05). This was compensated for by significant increases in the rates of glucose oxidation and glycolysis. The decreased fatty acid oxidation in PPARalpha (-/-) hearts was associated with increased levels of cardiac malonyl-CoA compared with PPARalpha (+/+) hearts (15.15 +/- 1.63 versus 7.37 +/- 1.31 nmol/g, dry weight, respectively, p < 0.05). Since malonyl-CoA is an important regulator of cardiac fatty acid oxidation, we also determined if the enzymes that control malonyl-CoA levels in the heart are under transcriptional control of PPARalpha. Expression of both mRNA and protein as well as the activity of malonyl-CoA decarboxylase, which degrades malonyl-CoA, were significantly decreased in the PPARalpha (-/-) hearts. In contrast, the expression and activity of acetyl-CoA carboxylase, which synthesizes malonyl-CoA and 5'-AMP-activated protein kinase, which regulates acetyl-CoA carboxylase, were not altered. Glucose transporter expression (GLUT1 and GLUT4) was not different between PPARalpha (-/-) and PPARalpha (+/+) hearts, suggesting that the increase in glycolysis and glucose oxidation in the PPARalpha null mice was not due to direct effects on glucose uptake but rather was occurring secondary to the decrease in fatty acid oxidation. This study demonstrates that PPARalpha is an important regulator of fatty acid oxidation in the heart and that this regulation of fatty acid oxidation may in part occur due to the transcriptional control of malonyl-CoA decarboxylase.
引用
收藏
页码:4098 / 4103
页数:6
相关论文
共 40 条
  • [31] SADDIK M, 1991, J BIOL CHEM, V266, P8162
  • [32] SADDIK M, 1993, J BIOL CHEM, V268, P25836
  • [33] Activation of malonyl-CoA decarboxylase in rat skeletal muscle by contraction and the AMP-activated protein kinase activator 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside
    Saha, AK
    Schwarsin, AJ
    Roduit, R
    Massé, F
    Kaushik, V
    Tornheim, K
    Prentki, M
    Ruderman, NB
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (32) : 24279 - 24283
  • [34] Contribution of malonyl-CoA decarboxylase to the high fatty acid oxidation rates seen in the diabetic heart
    Sakamoto, J
    Barr, RL
    Kavanagh, KM
    Lopaschuk, GD
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2000, 278 (04): : H1196 - H1204
  • [35] AMP-activated protein kinase:: greater AMP dependence, and preferential nuclear localization, of complexes containing the α2 isoform
    Salt, I
    Celler, JW
    Hawley, SA
    Prescott, A
    Woods, A
    Carling, D
    Hardie, DG
    [J]. BIOCHEMICAL JOURNAL, 1998, 334 : 177 - 187
  • [36] Cloning and expression of rat pancreatic β-cell malonyl-CoA decarboxylase
    Voilley, N
    Roduit, R
    Vicaretti, R
    Bonny, C
    Waeber, G
    Dyck, JRB
    Lopaschuk, GD
    Prentki, M
    [J]. BIOCHEMICAL JOURNAL, 1999, 340 : 213 - 217
  • [37] GLUCOSE-OXIDATION RATES IN FATTY ACID-PERFUSED ISOLATED WORKING HEARTS FROM DIABETIC RATS
    WALL, SR
    LOPASCHUK, GD
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1989, 1006 (01) : 97 - 103
  • [38] Constitutive regulation of cardiac fatty acid metabolism through peroxisome proliferator-activated receptor α associated with age-dependent cardiac toxicity
    Watanabe, K
    Fujii, H
    Takahashi, T
    Kodama, M
    Aizawa, Y
    Ohta, Y
    Ono, T
    Hasegawa, G
    Naito, M
    Nakajima, T
    Kamijo, Y
    Gonzalez, FJ
    Aoyama, T
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (29) : 22293 - 22299
  • [39] Regulation of cardiac and skeletal muscle malonyl-CoA decarboxylase by fatty acids
    Young, ME
    Goodwin, GW
    Ying, J
    Guthrie, P
    Wilson, CR
    Laws, FA
    Taegtmeyer, H
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2001, 280 (03): : E471 - E479
  • [40] Co-regulation of tissue-specific alternative human carnitine palmitoyltransferase Iβ gene promoters by fatty acid enzyme substrate
    Yu, GS
    Lu, YC
    Gulick, T
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (49) : 32901 - 32909